Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Stemtech (STEK) Share-based Compensation (2021 - 2025)

Historic Share-based Compensation for Stemtech (STEK) over the last 5 years, with Q3 2025 value amounting to $482148.0.

  • Stemtech's Share-based Compensation changed N/A to $482148.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $857938.0, marking a year-over-year increase of 4457.79%. This contributed to the annual value of $746374.0 for FY2024, which is 6999.59% up from last year.
  • Stemtech's Share-based Compensation amounted to $482148.0 in Q3 2025.
  • Stemtech's Share-based Compensation's 5-year high stood at $2.6 million during Q3 2022, with a 5-year trough of $1838.0 in Q3 2023.
  • Its 5-year average for Share-based Compensation is $384036.6, with a median of $184938.5 in 2024.
  • As far as peak fluctuations go, Stemtech's Share-based Compensation tumbled by 9992.98% in 2023, and later skyrocketed by 299755.05% in 2024.
  • Over the past 5 years, Stemtech's Share-based Compensation (Quarter) stood at $405169.0 in 2021, then surged by 186.32% to $1.2 million in 2022, then tumbled by 99.56% to $5103.0 in 2023, then surged by 2997.55% to $158068.0 in 2024, then soared by 205.03% to $482148.0 in 2025.
  • Its Share-based Compensation stands at $482148.0 for Q3 2025, versus $5913.0 for Q2 2025 and $211809.0 for Q1 2025.